CSF2 and melanoma: IL-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF) from an engineered oncolytic HSV have a synergistic effect, which boosts the immune response to enhance their antitumor effects in a B16-F10 murine melanoma model (Kim et al., 2021).